This activity is supported by educational grants from Gilead Sciences, AbbVie, Bristol-Myers Squibb, Merck, and Janssen Therapeutics.
HIV and Hepatitis Management 2017: THE NEW YORK COURSE - ART: What to Start and When to Switch This advanced continuing medical education activity will provide participants with state-of-the-art education and practical guidance from nationally and internationally recognized experts on HIV infection and related comorbidities.
This continuing education activity was planned to meet the needs of clinicians who treat patients with HIV.
Upon completion of this activity, participants should be able to:
List the ART regimens recommended for use in initial therapy by the DHHS and IAS-USA guidelines and discuss appropriate regimens for specific clinical scenarios
Discuss the rationale for switching or simplifying therapy in patients whose viral loads are suppressed on ART
Identify the strengths and weaknesses of two-drug regimens and induction-maintenance strategies that have been studied to date in clinical trials
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter rather than relying solely on the information contained in this material.
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of or promotion by Albert Einstein College of Medicine, Montefiore Medical Center, Mentor Planning & Consulting, Inc., or the program grantors. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Faculty Disclosure Policy
The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Joel E. Gallant, MD, MPH Medical Director of Specialty Services Southwest CARE Center Adjunct Professor of Medicine Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore, MD
Dr. Gallant has received grant/research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Sangamo BioSciences and ViiV Healthcare. He has served as a consultant for Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare.
AMA PRA Category 1 Credit(s)TM
The activity has been planned and implemented in accordance with requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and Mentor Planning & Consulting, Inc.
Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Albert Einstein College of Medicine designates this Internet Enduring Material for a maximum of 0.75 AMA PRA Category 1 creditsTM . Physicians should claim only credit commensurate with the extent of their participation in the activity.
Planners' and Managers' Disclosures
The staff of Mentor Planning & Consulting, Inc. and Hospital Learning Centers, Inc. have nothing to disclose relative to this educational activity. The Center for Continuing Medical Education staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.
Method of Participation
There are no fees to participate in this activity. To receive credit, participants must (1) read the intended audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test. It is estimated that this activity will take approximately 45 minutes. To receive AMA PRA Category 1 CreditTM participants must receive a minimum score of 70% on the post-test. Your online certificate will be saved on myCME within your CME History, which you can access at any time.